Therapeutic Implications of Oncogenic Missense HER2 (ERBB2) Mutations in Gastric Adenocarcinoma

Affiliations

• ¹ Northwell Health Cancer Institute and Feinstein Institute of Research, Lake Success, NY.
• ² Department of Pathology, Stanford University School of Medicine, Stanford, CA.
• ³ Department of Pathology, Billings Clinic, Billings, MT.
• ⁴ Early Drug Development Group, Stanford Cancer Institute, Stanford, CA.
• ⁵ Division of Oncology, Department of Internal Medicine, Stanford University, Stanford, CA.